The University of Chicago Header Logo

Risks and benefits of the use of concomitant immunosuppressives and biologics in inflammatory bowel disease.

Risks and benefits of the use of concomitant immunosuppressives and biologics in inflammatory bowel disease. Rev Gastroenterol Disord. 2008; 8(3):159-68.

View in: PubMed